Agree SE is STX's focus, OH, then WE. Unfortunately for us, they...

First 678 Last

Share
Profile

Follow
Justadabble

9,954 Posts.

3309

20/09/23

17:07

Post #: 69941356
Share

Originally posted by Ox270: ↑

So, can we all agree that there were a multitude of things causing delay? If we are in agreeance on this issue, then it comes down to lack of communication good, bad or benign. This is where we are all getting our knickers in a twist. It is passing strange that STX has not put out a Top 20 update since Feb. They were a monthly occurrence once, not a problem. Then, they went off the air issuing these. Field updates too became less frequent and those relating to Walyering in hindsight were overly optimistic or plain wrong in terms of timing. I don't know if W7 is myth just to get TPD holders over the line or will happen.
In a nutshell, if SOA falls over, I do not think TPD holders need ever worry about STX comms again or if they do it will be off into the far distant future. STX is smashing it SE with TD by 25th approx . 5kms deep in 35 days with breaks in between. It's future focus is likely SE, tidying up SOA then WE (50%) & Ocean Hill (100%). I know you holders need gas revenues as do STX holders .Ox

Expand

Agree SE is STX's focus, OH, then WE. Unfortunately for us, they want our cashflow to pay for it. In late June, everything was fine and dandy at Walyering, by 3rd July it was cooked. The pipeline application hadn't even been submitted in late June so the comms were, extracting from your post, both "bad" and "plain wrong". I have a lot of misgivings about getting on a bus that Stu is driving after this performance.

TPD Price at posting: 19.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

There are more pages in this discussion • 62 more messages in this thread...

First 678 Last

Add TPD (ASX) to my watchlist

Agree SE is STX's focus, OH, then WE. Unfortunately for us, they...

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Buxton projects new graphite province discovery at WA Narryer play

Featured News